A Phase I Trial of the VEGF Receptor Tyrosine Kinase Inhibitor Pazopanib in Combination with the MEK Inhibitor Trametinib in Advanced Solid Tumors and Differentiated Thyroid Cancers
VEGF 受体酪氨酸激酶抑制剂帕唑帕尼与 MEK 抑制剂曲美替尼联合治疗晚期实体瘤和分化型甲状腺癌的 I 期临床试验
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-18-1881
Razelle Kurzrock #, Douglas W Ball #, Marianna L Zahurak, Barry D Nelkin, Vivek Subbiah, Shabina Ahmed, Ashley O'Connor, Enusha Karunsena, Rose M Parkinson, Justin A Bishop, Yoonji Ha, Rajni Sharma, Christopher D Gocke, Ralph Zinner, Michelle A Rudek, Steven I Sherman #, Nilofer S Azad #
